Back to All Events

Antimicrobial Drugs Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

On Thursday, Mar 16, 2023, AMDAC will discuss NDA -217188 for PAXLOVID tablets submitted by Pfizer for the proposed indication of treatment of mild-to moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.


Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-information-march-16-2023-antimicrobial-drugs-advisory-committee-meeting-announcement#event-materials
Earlier Event: March 9
Oncology Drug Advisory Committee ([ODAC])
Later Event: March 22
Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)